Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization  | 
Drug Highest PhasePreclinical  | 
First Approval Date-  | 
Regulation-  | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Neoplasms | Preclinical | United States   | 08 Jan 2025 | |
| Neoplasms | Preclinical | China   | 08 Jan 2025 | 






